Literature DB >> 4319905

Mechanism of the growth inhibition potentiation arising from combination of 6-mercaptopurine with 6-(methylmercapto)purine ribonucleoside.

A R Paterson, M C Wang.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4319905

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  3 in total

1.  Pharmacokinetic and phase I study of intravenous DON (6-diazo-5-oxo-L-norleucine) in children.

Authors:  M P Sullivan; J A Nelson; S Feldman; B Van Nguyen
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

2.  Comparative study of 6-mercaptopurine metabolism in human leukemic leukocytes and L1210 cells.

Authors:  T Higuchi; T Nakamura; H Uchino; G Wakisaka
Journal:  Antimicrob Agents Chemother       Date:  1977-10       Impact factor: 5.191

3.  Purines as 'hyper-repressors' of glucose transport. A role for phosphoribosyl diphosphate.

Authors:  R J Gay; H Amos
Journal:  Biochem J       Date:  1983-07-15       Impact factor: 3.857

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.